AMD - AGE-RELATED MACULAR DEGENERATION
Clinical trials for AMD - AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new AMD - AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for AMD - AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill for macular degeneration enters first human safety tests
Symptom relief Recruiting nowThis early-stage study tests the safety of an experimental oral drug called ABF-101 in healthy adults and people with age-related macular degeneration (AMD). The goal is to see if the drug is safe and how the body processes it. About 68 participants will take single or multiple d…
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 05:27 UTC
-
Eye bleeding study seeks to predict who sees better after treatment
Knowledge-focused Recruiting nowThis study enrolls 60 people with age-related macular degeneration who have bleeding under the retina and are getting a procedure to move the blood. Researchers want to see if the type of abnormal blood vessel a person has affects how well their vision and eye structure recover. …
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Sponsor: Marco Mazzola • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC